This study is looking at whether using a cognitive training application on a smartphone or tablet can help reduce "chemobrain" (cancer-related cognitive impairment) in women with gynecologic cancer who are receiving chemotherapy. Chemobrain can cause difficulties with memory and clear thinking. The study will involve patients using this application and taking tests to measure their thinking abilities during and after chemotherapy. The goal is to see if this training can improve or prevent these cognitive difficulties. You may be able to join if you are a woman between 18 and 90 years old, have a newly diagnosed gynecologic cancer, are undergoing chemotherapy, and own a smartphone or tablet. The study aims to enroll 64 participants, but its current status is unclear.

Study design

This is an interventional study planning to enroll 64 women. It will test the effects of a cognitive training application.

What's involved

You would use a cognitive training application and undergo neurocognitive testing during and after chemotherapy.

Compensation

Not stated in the trial record.

Follow-up

Your neurocognitive function will be measured from the start of chemotherapy through 2 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.